Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer

ConclusionsWe provide multi-faceted evidence that SP142 PDL1-positive TNBC have immuno-genomic features characterized as highly lymphocyte-infiltrated and a relatively favorable survival.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research